Details werden geladen...
FDA Demands New Blindness Warning For GLP-1 Drugs
Health regulators have found a consistent link between GLP-1 use and the eye condition NAION.
Ähnliche Seiten
FDA orders new warning on GLP-1 drugs over potential risk of blindness | The National
https://www.thenationalnews.com/future/science/2026/11/10/do-glps1s-cause-blindness/
FDA Adds Vision Loss Warning To Popular GLP-1 Drugs | HuffPost Latest News
https://www.huffpost.com/entry/fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs_n_6af27d2ae4b08067d84b6679
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
https://www.nbcnews.com/health/health-care/fda-orders-new-warning-glp-1s-rare-eye-condition-linked-sudden-blindne-rcna608309
FDA to require vision loss warning on GLP-1 drug labels - National | Globalnews.ca
https://globalnews.ca/news/12144337/glp1-vision-loss-warning-fda/
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss - Ars Technica
https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns/